Zimmer Biomet Holdings, Inc. (ZBH) is a global medical technology company specializing in musculoskeletal healthcare. It designs and manufactures innovative orthopedic implants, surgical instruments, and digital solutions for joint reconstruction, trauma, and sports medicine. The company operates internationally with a corporate headquarters in Warsaw, Indiana. It has a market capitalization of $17.20 billion.
Zimmer Biomet is expected to report its second-quarter results for fiscal 2026 on Aug. 5, before the market opens. Ahead of the release, Wall Street analysts are tepid about the company’s bottom-line trajectory.